Halozyme (HALO) is up 11% to $50.99 in pre-market trading.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Halozyme withdraws proposal to acquire Evotec
- Halozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cash
- Spirit enters into bankruptcy proceedings, CVS names new directors: Morning Buzz
- Halozyme provides update on proposal to combine with Evotec
- Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz